Wockhardt sets timeline for resolving FDA bans; Sun profit suffers on Ranbaxy fold-in;

@FiercePharma: Tech makers market health wearables to dog owners. FierceAnimalHealth story | Follow @FiercePharma

@CarlyHFierce: ICYMI yesterday: Lundbeck's EU lobbying yields political boost for anti-alcohol med Selincro. Article | Follow @CarlyHFierce

> Wockhardt hopes to resolve the FDA ban on two of its plants by the end of its current fiscal year. More

> Sun Pharma's profits for the three months ended March 31 missed analysts estimates thanks to the cost of integrating new buy Ranbaxy Laboratories. Report

> A jury has ordered Abbott Laboratories ($ABT) to pay $23 million in punitive damages to a Minnesota girl whose family blamed the company's epilepsy drug Depakote for causing her birth defects. More

> The FDA has approved Pfizer's ($PFE) Rapamune to treat a rare lung disease. Report

Medical Device News

@FierceMedDev: ICYMI yesterday: Deerfield backs startup with $10M for its hemodialysis vascular access implant. Article | Follow @FierceMedDev

@VarunSaxena2: UPDATED w/ info from the company: CareFusion's Avea ventilator recalled as potentially deadly. Story | Follow @VarunSaxena2

@EmilyWFierce: Boston Scientific slapped with $100M verdict in vaginal mesh suit. News | Follow @EmilyWFierce

> Zimmer to divest three U.S. businesses to appease FTC, hit mid-June Biomet acquisition close. More

> Nonprofit leads $17.5M round for medical image exchange startup LifeImage. Article

Biotech News

@FierceBiotech: Buzz: Cellectis could be in a line for a $1.6B Pfizer buyout. Article | Follow @FierceBiotech

@JohnCFierce: Is this a good time to tout my survey (with Bloomberg Intelligence)? Are biotech assets overvalued? Check it out | Follow @JohnCFierce

> Merck hands its hep C combo to the FDA with sights on Gilead and AbbVie. More

> Heron soars as twice-rejected nausea drug comes through in Phase III. Report

And Finally... HIV treatment with antiretroviral drugs should begin immediately following diagnosis, U.S. health officials say. More (sub. req.)

Suggested Articles

Transporting pharmaceutical products at <-60C for more than 96 hours has seemed an insurmountable challenge. TOWER’s solution has solved the problem.

The countdown to the FDA's first coronavirus vaccine hearing has begun, and new agency documents outline an agenda for the Thursday confab.

Black Americans’ confidence in COVID-19 vaccines is dropping, with only 43% saying they will get a vaccine once it's out—down 22 points since August.